COVID Antiviral Pills Require Access To Speedy And Accurate Tests
Experts say the success of the new pills hinge on whether high-risk patients will be able to get tested — and then treated — fast enough to make a difference.
Experts say the success of the new pills hinge on whether high-risk patients will be able to get tested — and then treated — fast enough to make a difference.
At least three promising antivirals for COVID are being tested in clinical trials, with results expected as soon as late fall or winter.